Please login to the form below

Not currently logged in
Email:
Password:

Takeda launches drug discovery biotech

Hopes Bridge Medicines will streamline the development process

TakedaTakeda has joined forces with three US academic institutions to launch a drug discovery company whose mission is to speed the development of innovative therapies.

New-York-based biotech Bridge Medicines will provide a fully-funded path from concept to drug candidate, eschewing time-consuming searches for investors and product licensers that can often bring a halt to a drug's development.

It builds on work from the Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) - a partnership created in 2013 by the Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine.

Tri-I TDI currently has 50 early-stage research drug discovery projects underway and these will also benefit from Bridge Medicines' financial, operational and managerial support.

Dr Michael Foley, Sanders director of the Tri-I TDI, said: “The launch of Bridge Medicines is a truly exciting development in New York's biotechnology space.

“We're tapping into the distinguished talent at Sloan Kettering, Rockefeller and Weill Cornell Medicine and offering entrepreneurs access to support what's next in biopharmaceuticals.

“Bridge Medicines will enable us to advance promising projects farther down the development pipeline, providing new therapies to patients as quickly as possible.”

The collaboration between Takeda and the Tri-I TDI enables funding of potentially transformational but risky research projects thanks to the partnership's group model, which has the support of healthcare investment firms Bay City Capital and Deerfield Management.

Dr Foley added: “Bridge Medicines' mission is to increase the odds of successfully developing novel therapeutics to meet the needs of patients while simultaneously helping to build a vibrant biotechnology sector in New York City.”

Article by
Rebecca Clifford

1st November 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics